B cells and tertiary lymphoid structures promote immunotherapy response

Journal: Nature

Published: 2020-01-15

DOI: 10.1038/s41586-019-1922-8

Affiliations: 27

Authors: 60

Go to article
Institutions Share
Department of Surgical Oncology, MD Anderson Cancer Center, United States of America (USA) 0.19
Department of Melanoma Medical Oncology, MD Anderson Cancer Center, United States of America (USA) 0.10
Division of Molecular Oncology and Immunology, NKI, Netherlands 0.10
Department of Genomic Medicine, MD Anderson Cancer Center, United States of America (USA) 0.08
Department of Immunology, MD Anderson Cancer Center, United States of America (USA) 0.08
Department of Cancer Biology, MD Anderson Cancer Center, United States of America (USA) 0.05
NanoString Technologies, Inc., United States of America (USA) 0.05
Department of Pathology, MD Anderson Cancer Center, United States of America (USA) 0.05
Cordelier Research Center (CRC), France 0.04
Department of Stem Cell Transplantation and Cellular Therapy, MD Anderson Cancer Center, United States of America (USA) 0.03
Department of Epigenetics and Molecular Carcinogenesis, MD Anderson Cancer Center, United States of America (USA) 0.03
Department of Genitourinary Medical Oncology, MD Anderson Cancer Center, United States of America (USA) 0.03
Department of Medicine, MGH, United States of America (USA) 0.02
Cancer Center, MGH, United States of America (USA) 0.02
Immunology Program, MSKCC, United States of America (USA) 0.02
Parker Institute for Cancer Immunotherapy, United States of America (USA) 0.02
Department of Breast Medical Oncology, MD Anderson Cancer Center, United States of America (USA) 0.02
Department of Thoracic/Head and Neck Medical Oncology, MD Anderson Cancer Center, United States of America (USA) 0.02
Department of Bioinformatics and Computational Biology, MD Anderson Cancer Center, United States of America (USA) 0.02
Department of Translational Molecular Pathology, MD Anderson Cancer Center, United States of America (USA) 0.01
Broad Institute of MIT and Harvard, United States of America (USA) 0.01
Cartes d’Identité des Tumeurs (CIT), Ligue Contre Le Cancer, France 0.01
Department of Immunology, Pitt, United States of America (USA) 0
Clinical and Translational Science Institute (CTSI), Pitt, United States of America (USA) 0
Department of Surgery, Pitt, United States of America (USA) 0
Department of Medicine, Pitt, United States of America (USA) 0

Return

Except where otherwise noted © 2021 Springer Nature Limited. All Rights Reserved.
partner of AGORA, HINARI, OARE, INASP, ORCID, CrossRef and COUNTER